Carbetapentane
Carbetapentane has an atropine-like action that depresses the cough reflex by selective central nervous system depression. Carbetapentane is frequently combined with one or more antihistaminic drugs such as pyrilamine. Such combination, in the form of their tannate salts is frequently administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis, unproductive cough and upper respiratory tract conditions
Primary Characteristics
It is of Synthetic origin.
Molecular Weight: 525.59 · Non-proprietary name: Carbetapentane.

Pharmacokinetics
Absorption: Carbetapentane has an oral bioavailability is 60.5% (±11.5%).
Elimination: plasma half-life is 2.3 hrs.
Advertisement
Indications
Carbetapentane is primarily indicated in conditions like Allergy, Cough suppressant, Hay fever, Nasal congestion.
Carbetapentane is also indicated for secondary conditions like Sinusitis.
Contraindications
Carbetapentane is contraindicated in conditions like Hypertension, Coronary artery disease, Hypersensitivity to the drug.
Dosage
None recorded.
Drug Interactions
None recorded.
Side Effects
Carbetapentane in overdosage may give rise to further complications which include Hallucinations , Fever , Anxiety , Dizziness , Chills , Irregular heart beat.
Carbetapentane is known to cause more or less tolerable side effects which are usually transient. These include Dry mucous membrane (perticularly dry mouth, throat, and nose), Insomnia, Paradoxical excitement, Restlessness, Skin rash, Stomach upset.
Warnings / Precautions
Available Brands
None recorded.
Storage Conditions
Drug Classification
- 1.3 — Anti-allergics (Antihistamines) and drugs used in anaphylaxis